茯苓酸对人胰腺癌PANC-1细胞迁移、侵袭和上皮间质转化的抑制作用

doi:10.13481/j.1671-587X.20230207

摘要/Abstract

摘要：

目的探讨茯苓酸（PA）通过上调活化转录因子3（ATF3）和热休克蛋白家族A成员6（HSPA6）表达对胰腺癌PANC-1细胞迁移、侵袭和上皮间质转化（EMT）的作用，并阐明其可能的作用机制。方法胰腺癌PANC-1细胞分为空白对照组和不同浓度（2、5、10、20、30、40和50 μmol·L^－1）PA处理组，采用CCK-8法检测各组PANC-1细胞的细胞活性。不同浓度（0、10、30和50 μmol·L^－1）PA作用于PANC-1细胞，采用Transwell小室实验检测PANC-1细胞迁移和侵袭能力，Western blotting法检测PANC-1细胞中EMT相关蛋白表达水平。将10只BALB/c nude裸鼠随机分为对照组和PA组，每组5只，裸鼠皮下注射PANC-1细胞，待肿瘤体积达到60 mm³时，PA组裸鼠腹腔注射25 mg·kg^－1PA，对照组裸鼠注射等量生理盐水，测量肿瘤体积和瘤质量，免疫组织化学法检测各组裸鼠移植瘤组织中Ki-67表达情况。通过GEO2R软件分析GSE64111数据集中PA处理及未处理胰腺癌细胞的差异表达基因。不同浓度（0和30 μmol·L^－1）PA作用于PANC-1细胞，采用Western blotting法检测PANC-1细胞中HSPA6和ATF3蛋白表达水平。将30 μmol·L^－1PA处理的PANC-1细胞分为si-NC组和si-ATF3组，分别转染对照siRNA和ATF3 siRNA，采用Western blotting法检测各组细胞中HSPA6和ATF3蛋白及EMT相关蛋白表达水平，Transwell小室实验检测细胞迁移和侵袭能力。结果 CCK-8法，与空白对照组比较，不同浓度PA处理组PANC-1细胞的细胞活性呈浓度依赖性降低（P<0.05）。Transwell小室实验，与空白对照组比较，不同浓度PA处理组PANC-1细胞迁移能力和侵袭能力呈浓度依赖性降低（P<0.05）。Western blotting法，与空白对照组比较，不同浓度PA组PANC-1细胞中上皮钙黏素蛋白表达水平升高（P<0.05），神经钙黏素和波形蛋白表达水平降低（P<0.05）。裸鼠成瘤实验，与对照组比较，PA组裸鼠移植瘤体积和瘤质量明显降低（P<0.05）；免疫组织化学，与对照组比较，PA组裸鼠移植瘤Ki-67染色较浅。GEO2R软件分析和Western blotting法，与空白对照组比较，PA处理组PANC-1细胞中HSPA6和ATF3蛋白表达水平明显升高（P<0.05）。Western blotting法，与si-NC组比较，si-ATF3组PANC-1细胞中HSPA6、ATF3和上皮钙黏素蛋白表达水平明显降低（P<0.05），神经钙黏素和波形蛋白表达水平明显升高（P<0.05）。Transwell小室实验，与si-NC组比较，si-ATF3组PANC-1细胞迁移和侵袭能力明显增加（P<0.05）。结论 PA通过上调HSPA6和ATF3表达抑制胰腺癌细胞迁移、侵袭和EMT，从而发挥抗胰腺癌作用。

关键词: 茯苓酸, 胰腺肿瘤, PANC-1细胞, 上皮间质转化, 细胞迁移, 细胞侵袭, 活化转录因子3, 热休克蛋白家族A成员6

Abstract:

Objective To investigate the effect of poiaic acid （PA） on the migration， invasion， and epithelial-mesenchymal transition（EMT） of the pancreatic cancer PANC-1 cells by up regulating the expressions of activating transcription factor 3 （ATF3） and heat shock protein family A member 6（HSPA6），and to clarify its possible mechanism. Methods The pancreatic cancer PANC-1 cells were divided into blank control group and different concentrations （2，5，10，20，30，40， and 50 μmol·L^－1）of PA groups，and the activities of the PANC-1 cells in various groups were detected by CCK-8 method. The PANC-1 cells were treated with different concentrations （0， 10， 30， and 50 μmol·L^－1） of PA， and the migration and invasion abilities of the PANC-1 cells were detected by Transwell chamber experiment， and the expression level of EMT-related proteins in the PANC-1 cells were detected by Western blotting method. A total of 10 BALB/c nude mice were randomly divided into control group and PA group， and there were 5 mice in each group. The PANC-1 cells were subcutaneously injected into the nude mice. When the tumor volume reached 60 mm³， the nude mice in PA group were intraperitoneally injected with 25 mg·kg^－1 PA， and the nude mice in control group were injected with the same volume of normal saline， the tumor volume and tumor weight of the mice in various groups were measured， and the expressions of Ki-67 in xenografted tissue of the mice in various groups were detected by immunohistochemistry. The differentially expressed genes of the PA-treated and PA-untreated pancreatic cancer cells in the GSE64111 Dataset were analyzed by GEO2R software. The PANC-1 cells were treated with different concentrations（0 and 30 μmol·L^－1） of PA， and the expression levels of HSPA6 and ATF3 proteins in the PANC-1 cells were detected by Western blotting method. The PANC-1 cells treated with 30 μmol·L^－1 PA were randomly divided into si-NC group and si-ATF3 group， and the cells were transfected with control siRNA and ATF3 siRNA， respectively. The expression levels of HSPA6 and ATF3 proteins and EMT-related proteins in the PANC-1 cells in various groups were detected by Western blotting method， and the migration and invasion abilities of the cells were detected by Transwell chamber experiment. Results The CCK-8 experiment results showed that compared with blank control group， the activities of the PANC-1 cells in different concentrations of PA groups were significantly decreased （P<0.05）.The results of Transwell chamber experiment showed that compared with blank control group， the migration and invasion abilities of the PANC-1 cells in different concentrations of PA groups were significantly decreased （P<0.05），and showed a concentration depent manner. The Western blotting results showed that compared with blank control group， the expression levels of E-cadherin protein in the PANC-1 cells in different concentrations of PA groups were significantly increased （P<0.05）， while the expression levels of N-cadherin and Vimentin proteins were significantly decreased （P<0.05）.The results of tumor formation in the nude mice showed that compared with control group， the volume and weight of the xenografted of the mice in PA group were significantly decreased （P<0.05）；the immunohistochemistry results showed that the Ki-67 staining in xeografted was shallow； the GEO2R software analysis and Western blotting results showed that compared with blank control group， the expression levels of HSPA6 and ATF3 proteins in the PANC-1 cells in PA group were significantly increased （P<0.05）. The Western blotting results showed that compared with si-NC group， the expression levels of ATF3， HSPA6， and E-cadherin proteins in the PANC-1 cells in si-ATF3 group were significantly decreased （P<0.05）， while the expression levels of N-cadherin and Vimentin proteins were significantly increased （P<0.05）.The Transwell chamber experiment results showed that compared with si-NC group， the migration and invasion abilities of the PANC-1 cells in si-ATF3 group were significantly increased （P<0.05）. Conclusion PA inhibits the migration， invasion， and EMT of the pancreatic cancer cells by up-regulating the expressions of HSPA6 and ATF3， thus play an anti-pancreatic cancer effect.

Key words: Pachymic acid, Pancreatic neoplasm, PANC-1 cells, Epithelial-mesenchymal transition, Cell migration, Cell invasion, Activating transcription factor 3, Heat shock protein family A member 6

中图分类号:

R735.9

李锐,谭晓冬,胡耀元. 茯苓酸对人胰腺癌PANC-1细胞迁移、侵袭和上皮间质转化的抑制作用[J]. 吉林大学学报(医学版), 2023, 49(2): 315-323.

Rui LI,Xiaodong TAN,Yaoyuan HU. Inhibitory effect of pachylic acid on migration, invasion, and epithelial-mesenchymal transition of human pancreatic cancer PANC-1 cells[J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 315-323.

图/表 11

表1

图1

图2

图3

图4

图5

图6

图7

图8

图9

图10

参考文献 22

1	SIEGEL R L， MILLER K D， FUCHS H E， et al. Cancer statistics， 2021［J］. CA Cancer J Clin， 2021， 71（1）： 7-33.
2	OLDFIELD L E， CONNOR A A， GALLINGER S. Molecular events in the natural history of pancreatic cancer［J］. Trends Cancer， 2017， 3（5）： 336-346.
3	SIEGEL R L， MILLER K D， JEMAL A. Cancer statistics， 2020［J］.CA Cancer J Clin，2020，70（1）： 7-30.
4	GAO Y， CHEN S Y， SUN J Y， et al. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer： a review［J］. Phytother Res， 2021， 35（2）： 603-628.
5	CÖR D， KNEZ Ž， KNEZ HRNCIC M K. Antitumour， antimicrobial， antioxidant and antiacetylcholinesterase effect of ganoderma lucidum terpenoids and polysaccharides：a review［J］.Molecules，2018，23（3）：649.
6	JIANG G P， LIAO Y J， HUANG L L， et al. Effects and molecular mechanism of pachymic acid on ferroptosis in renal ischemia reperfusion injury［J］. Mol Med Rep， 2021， 23（1）： 63.
7	CHENG S J， SWANSON K， ELIAZ I， et al. Pachymic acid inhibits growth and induces apoptosis of pancreatic cancer in vitro and in vivo by targeting ER stress［J］. PLoS One， 2015， 10（4）： e0122270.
8	BRUNETTI O， APRILE G， MARCHETTI P， et al. Systemic chemotherapy for advanced rare pancreatic histotype tumors： a retrospective multicenter analysis［J］. Pancreas， 2018， 47（6）： 759-771.
9	GAO A H， ZHANG L， CHEN X， et al. Inhibition of ovarian cancer proliferation and invasion by pachymic acid［J］. Int J Clin Exp Pathol， 2015， 8（2）： 2235-2241.
10	CHENG S J， ELIAZ I， LIN J F， et al. Triterpenes from Poria Cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7［J］. Int J Oncol， 2013， 42（6）： 1869-1874.
11	ZHOU P T， LI B， LIU F R， et al. The epithelial to mesenchymal transition （EMT） and cancer stem cells： implication for treatment resistance in pancreatic cancer［J］. Mol Cancer， 2017， 16（1）： 52.
12	WANG S， HUANG S， SUN Y L. Epithelial-mesenchymal transition in pancreatic cancer：a review ［J］. Biomed Res Int， 2017， 2017： 2646148.
13	DONGRE A， WEINBERG R A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer［J］. Nat Rev Mol Cell Biol， 2019， 20（2）： 69-84.
14	LIAO T T， YANG M H. Revisiting epithelial-mesenchymal transition in cancer metastasis： the connection between epithelial plasticity and stemness［J］. Mol Oncol， 2017， 11（7）： 792-804.
15	ZHANG Y， WEINBERG R A. Epithelial-to-mesenchymal transition in cancer： complexity and opportunities［J］. Front Med， 2018， 12（4）： 361-373.
16	FA J J， ZHANG X Q， ZHANG X P， et al. Long noncoding RNA lnc-TSSK2-8 activates canonical Wnt/ β-catenin signaling through small heat shock proteins HSPA6 and CRYAB［J］. Front Cell Dev Biol， 2021， 9： 660576.
17	SHEN S Y， WEI C L， FU J J. RNA-sequencing reveals heat shock 70-kDa protein 6 （HSPA6） as a novel thymoquinone-upregulated gene that inhibits growth， migration， and invasion of triple-negative breast cancer cells［J］. Front Oncol， 2021， 11： 667995.
18	COTO-LLERENA M， TOSTI N， TAHA-MEHLITZ S，et al. Transcriptional enhancer factor domain family member 4 exerts an oncogenic role in hepatocellular carcinoma by hippo-independent regulation of heat shock protein 70 family members［J］. Hepatol Commun， 2021， 5（4）： 661-674.
19	ZHOU X， JI Q K， LI Q， et al. HSPA6 is correlated with the malignant progression and immune microenvironment of gliomas［J］. Front Cell Dev Biol， 2022， 10： 833938.
20	KU H C， CHENG C F. Master regulator activating transcription factor 3 （ATF3） in metabolic homeostasis and cancer［J］.Front Endocrinol （Lausanne），2020，11：556.
21	YOUNS M， ASKOURA M， ABBAS H A， et al. Celastrol modulates multiple signaling pathways to inhibit proliferation of pancreatic cancer via DDIT3 and ATF3 up-regulation and RRM2 and MCM4 down-regulation［J］. Onco Targets Ther， 2021，14：3849-3860.
22	DUNCAN R M， REYES L， MOATS K， et al. ATF3 coordinates antitumor synergy between epigenetic drugs and protein disulfide isomerase inhibitors［J］. Cancer Res， 2020， 80（16）： 3279-3291.

Group	Cell activity
Blank control	100.00±4.71
PA(μmol·L^－1)
2	96.31±7.15
5	88.49±3.56^*
10	78.50±3.90^*
20	71.13±4.02^*
30	59.33±3.34^*
40	40.67±7.69^*
50	22.40±3.83^*

[1]	王开,黄汉. 阿托伐他汀对人舌鳞癌CAL-27细胞增殖、凋亡和迁移的影响及其机制[J]. 吉林大学学报(医学版), 2023, 49(2): 324-331.
[2]	孙逸飞,李迪诺,王玉彬. 姜黄素通过下调PI3K/Akt/mTOR信号通路蛋白表达对胃癌MGC-803细胞增殖和侵袭的抑制作用[J]. 吉林大学学报(医学版), 2023, 49(2): 332-340.
[3]	孙利军,冯杰,刘小明,任广伟,阮琳. ADAM10在人动静脉内瘘狭窄处血管组织中的表达及其对血管平滑肌细胞增殖和迁移的影响[J]. 吉林大学学报(医学版), 2023, 49(2): 482-491.
[4]	金俊伊,李木,胡耀元,王熠辉. miR-150-5p与NCAPG的靶向关系及其对肝细胞肝癌Huh7细胞的抑制作用[J]. 吉林大学学报(医学版), 2023, 49(1): 122-130.
[5]	陈艳雅,招锦兰,李婵,黄丽珊. 卵巢癌组织中miR-223的表达及其对卵巢癌OVCAR3细胞增殖和侵袭的促进作用[J]. 吉林大学学报(医学版), 2023, 49(1): 150-157.
[6]	赵杰,周宁,刘冬芹,代娟娟,王丹丹,武艳. 上调Mg²⁺/Mn²⁺依赖性蛋白磷酸酶1F表达对鼻咽癌HONE-1细胞增殖和迁移的影响[J]. 吉林大学学报(医学版), 2023, 49(1): 39-45.
[7]	武晓慧,杨帆,郭新茹,袁轲,马综艺,廉婷,JHA Rajiv Kumar. 奥利司他联合EZH2抑制剂GSK126对胰腺癌细胞脂质代谢重编程的影响[J]. 吉林大学学报(医学版), 2023, 49(1): 55-66.
[8]	刘云,朱琳琦,邵世和. 环状RNA hsa_circ_0009735对胃癌细胞上皮间质转化、细胞周期和自噬的影响[J]. 吉林大学学报(医学版), 2022, 48(6): 1498-1509.
[9]	黄晓妹,王洪伟,韩贞艳,韦秋园,黄素静. lncRNA GHET1通过Wnt/β-catenin信号通路对子痫前期滋养层细胞生物学行为的影响[J]. 吉林大学学报(医学版), 2022, 48(5): 1324-1332.
[10]	王志娟,张明姝,叶丽平. 血小板衍生生长因子D通过ERK信号通路对肺癌H1299细胞增殖、迁移和侵袭的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(4): 898-904.
[11]	马琰迪,卢香云,何尚峰,俞雪燕,胡云华,高海霞,陈云昭,禹洁,王文洁,李锋,崔晓宾. m6A甲基化修饰结合蛋白YTHDF2在食管癌组织中的表达及其对食管癌细胞增殖和迁移的影响[J]. 吉林大学学报(医学版), 2022, 48(4): 962-970.
[12]	汪国武,姚远,张雨,徐娜,刘芳. miR-152降低低密度脂蛋白受体表达对子宫内膜癌细胞增殖和侵袭的抑制作用[J]. 吉林大学学报(医学版), 2022, 48(3): 591-599.
[13]	刘翠兰,胡凤爱,刘晶,王丹,邱长云,柳敦江,赵娣. 脂联素受体激动剂AdiopRon对胶质瘤细胞生物学行为的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 702-710.
[14]	吴壮志,贺小宁,陈思祺. miR-124-3p对口腔鳞状细胞癌细胞增殖和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 718-727.
[15]	李承圣,包绮晗,郝晓燕,潘庆忠,王素珍,石福艳. 基于随机森林算法的胰腺癌术后预测模型构建[J]. 吉林大学学报(医学版), 2022, 48(2): 426-435.